secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0000950170-25-065057
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TuHURA amends Kineta merger; revises consideration, extends end date to June 30, 2025
--------------------------------------------------------------------------------

- First Amendment revises merger consideration: Initial Stock Consideration based on $16.5M less adjustments at $5.7528/share.
- Delayed Stock Consideration set at $6.5M less liabilities and working capital deficits, divided by share value and fully diluted shares.
- Cash Consideration base $12M, with credits for $5M exclusivity, $300K extension, $695K advances, loaned amount, and working capital adjustment.
- End Date extended to June 30, 2025; closing condition requires TuHURA to receive at least $20M from concurrent investment.
- CSO Dennis Yamashita terminated Dec 16, 2024; severance $145,833 over 5 months, COBRA 6 months, options vest on 65,597 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000095017025065057/0000950170-25-065057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000095017025065057/hura-20250505.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-065057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer